SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
OLIG2
|
ENSG00000205927.4 | oligodendrocyte transcription factor 2 |
NEUROD1
|
ENSG00000162992.3 | neuronal differentiation 1 |
ATOH1
|
ENSG00000172238.3 | atonal bHLH transcription factor 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
OLIG2 | hg19_v2_chr21_+_34398153_34398250 | -0.16 | 5.0e-01 | Click! |
ATOH1 | hg19_v2_chr4_+_94750014_94750042 | -0.15 | 5.2e-01 | Click! |
NEUROD1 | hg19_v2_chr2_-_182545603_182545603 | 0.12 | 6.0e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr8_-_49834299 | 2.28 |
ENST00000396822.1
|
SNAI2
|
snail family zinc finger 2 |
chr8_-_49833978 | 2.28 |
ENST00000020945.1
|
SNAI2
|
snail family zinc finger 2 |
chr12_+_4382917 | 1.71 |
ENST00000261254.3
|
CCND2
|
cyclin D2 |
chr3_-_99833333 | 1.69 |
ENST00000354552.3
ENST00000331335.5 ENST00000398326.2 |
FILIP1L
|
filamin A interacting protein 1-like |
chr3_-_18480260 | 1.52 |
ENST00000454909.2
|
SATB1
|
SATB homeobox 1 |
chr12_+_113416191 | 1.50 |
ENST00000342315.4
ENST00000392583.2 |
OAS2
|
2'-5'-oligoadenylate synthetase 2, 69/71kDa |
chr11_+_57365150 | 1.48 |
ENST00000457869.1
ENST00000340687.6 ENST00000378323.4 ENST00000378324.2 ENST00000403558.1 |
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 |
chr3_-_195310802 | 1.41 |
ENST00000421243.1
ENST00000453131.1 |
APOD
|
apolipoprotein D |
chr3_+_118892411 | 1.39 |
ENST00000479520.1
ENST00000494855.1 |
UPK1B
|
uroplakin 1B |
chr3_+_118892362 | 1.33 |
ENST00000497685.1
ENST00000264234.3 |
UPK1B
|
uroplakin 1B |
chr19_-_11450249 | 1.28 |
ENST00000222120.3
|
RAB3D
|
RAB3D, member RAS oncogene family |
chr5_+_49962772 | 1.19 |
ENST00000281631.5
ENST00000513738.1 ENST00000503665.1 ENST00000514067.2 ENST00000503046.1 |
PARP8
|
poly (ADP-ribose) polymerase family, member 8 |
chr4_+_1795012 | 1.11 |
ENST00000481110.2
ENST00000340107.4 ENST00000440486.2 ENST00000412135.2 |
FGFR3
|
fibroblast growth factor receptor 3 |
chr6_+_30851840 | 1.10 |
ENST00000511510.1
ENST00000376569.3 ENST00000376575.3 ENST00000376570.4 ENST00000446312.1 ENST00000504927.1 |
DDR1
|
discoidin domain receptor tyrosine kinase 1 |
chr12_+_113416340 | 1.09 |
ENST00000552756.1
|
OAS2
|
2'-5'-oligoadenylate synthetase 2, 69/71kDa |
chr1_+_6508100 | 1.04 |
ENST00000461727.1
|
ESPN
|
espin |
chr11_+_44587141 | 1.02 |
ENST00000227155.4
ENST00000342935.3 ENST00000532544.1 |
CD82
|
CD82 molecule |
chr2_-_163100045 | 1.02 |
ENST00000188790.4
|
FAP
|
fibroblast activation protein, alpha |
chr17_+_7341586 | 1.01 |
ENST00000575235.1
|
FGF11
|
fibroblast growth factor 11 |
chr19_-_4338783 | 1.00 |
ENST00000601482.1
ENST00000600324.1 |
STAP2
|
signal transducing adaptor family member 2 |
chr1_-_209792111 | 1.00 |
ENST00000455193.1
|
LAMB3
|
laminin, beta 3 |
chr5_+_102201722 | 0.91 |
ENST00000274392.9
ENST00000455264.2 |
PAM
|
peptidylglycine alpha-amidating monooxygenase |
chr19_+_41222998 | 0.91 |
ENST00000263370.2
|
ITPKC
|
inositol-trisphosphate 3-kinase C |
chr5_+_102201687 | 0.89 |
ENST00000304400.7
|
PAM
|
peptidylglycine alpha-amidating monooxygenase |
chr11_+_44587206 | 0.89 |
ENST00000525210.1
ENST00000527737.1 ENST00000524704.1 |
CD82
|
CD82 molecule |
chr3_-_18480173 | 0.86 |
ENST00000414509.1
|
SATB1
|
SATB homeobox 1 |
chr7_-_41742697 | 0.85 |
ENST00000242208.4
|
INHBA
|
inhibin, beta A |
chr13_-_20767037 | 0.85 |
ENST00000382848.4
|
GJB2
|
gap junction protein, beta 2, 26kDa |
chr3_+_49840685 | 0.82 |
ENST00000333323.4
|
FAM212A
|
family with sequence similarity 212, member A |
chr5_+_102201509 | 0.79 |
ENST00000348126.2
ENST00000379787.4 |
PAM
|
peptidylglycine alpha-amidating monooxygenase |
chr18_+_59415396 | 0.76 |
ENST00000567801.1
|
RP11-1096D5.1
|
RP11-1096D5.1 |
chr12_+_6309963 | 0.75 |
ENST00000382515.2
|
CD9
|
CD9 molecule |
chr1_-_153363452 | 0.74 |
ENST00000368732.1
ENST00000368733.3 |
S100A8
|
S100 calcium binding protein A8 |
chr12_-_48152428 | 0.73 |
ENST00000449771.2
ENST00000395358.3 |
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3 |
chr9_-_33447584 | 0.69 |
ENST00000297991.4
|
AQP3
|
aquaporin 3 (Gill blood group) |
chr10_-_105437909 | 0.68 |
ENST00000540321.1
|
SH3PXD2A
|
SH3 and PX domains 2A |
chr21_+_30502806 | 0.68 |
ENST00000399928.1
ENST00000399926.1 |
MAP3K7CL
|
MAP3K7 C-terminal like |
chr1_+_12524965 | 0.67 |
ENST00000471923.1
|
VPS13D
|
vacuolar protein sorting 13 homolog D (S. cerevisiae) |
chr12_-_52845910 | 0.67 |
ENST00000252252.3
|
KRT6B
|
keratin 6B |
chr17_-_56492989 | 0.67 |
ENST00000583753.1
|
RNF43
|
ring finger protein 43 |
chr19_+_45281118 | 0.66 |
ENST00000270279.3
ENST00000341505.4 |
CBLC
|
Cbl proto-oncogene C, E3 ubiquitin protein ligase |
chr12_+_113416265 | 0.65 |
ENST00000449768.2
|
OAS2
|
2'-5'-oligoadenylate synthetase 2, 69/71kDa |
chr1_-_201346761 | 0.63 |
ENST00000455702.1
ENST00000422165.1 ENST00000367318.5 ENST00000367320.2 ENST00000438742.1 ENST00000412633.1 ENST00000458432.2 ENST00000421663.2 ENST00000367322.1 ENST00000509001.1 |
TNNT2
|
troponin T type 2 (cardiac) |
chr15_+_75940218 | 0.63 |
ENST00000308527.5
|
SNX33
|
sorting nexin 33 |
chr19_-_51466681 | 0.63 |
ENST00000456750.2
|
KLK6
|
kallikrein-related peptidase 6 |
chr3_+_118905564 | 0.59 |
ENST00000460625.1
|
UPK1B
|
uroplakin 1B |
chrX_+_9880412 | 0.58 |
ENST00000418909.2
|
SHROOM2
|
shroom family member 2 |
chr2_+_69001913 | 0.58 |
ENST00000409030.3
ENST00000409220.1 |
ARHGAP25
|
Rho GTPase activating protein 25 |
chr20_+_33292507 | 0.57 |
ENST00000414082.1
|
TP53INP2
|
tumor protein p53 inducible nuclear protein 2 |
chr5_+_102201430 | 0.57 |
ENST00000438793.3
ENST00000346918.2 |
PAM
|
peptidylglycine alpha-amidating monooxygenase |
chr12_-_58145889 | 0.57 |
ENST00000547853.1
|
CDK4
|
cyclin-dependent kinase 4 |
chr11_+_128634589 | 0.56 |
ENST00000281428.8
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor |
chr12_+_69201923 | 0.56 |
ENST00000462284.1
ENST00000258149.5 ENST00000356290.4 ENST00000540827.1 ENST00000428863.2 ENST00000393412.3 |
MDM2
|
MDM2 oncogene, E3 ubiquitin protein ligase |
chr22_+_17082732 | 0.55 |
ENST00000558085.2
ENST00000592918.1 ENST00000400593.2 ENST00000592107.1 ENST00000426585.1 ENST00000591299.1 |
TPTEP1
|
transmembrane phosphatase with tensin homology pseudogene 1 |
chr8_-_128231299 | 0.54 |
ENST00000500112.1
|
CCAT1
|
colon cancer associated transcript 1 (non-protein coding) |
chr4_-_24914576 | 0.54 |
ENST00000502801.1
ENST00000428116.2 |
CCDC149
|
coiled-coil domain containing 149 |
chr12_-_57634475 | 0.53 |
ENST00000393825.1
|
NDUFA4L2
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4-like 2 |
chr4_-_24914508 | 0.52 |
ENST00000504487.1
|
CCDC149
|
coiled-coil domain containing 149 |
chr12_+_6309517 | 0.52 |
ENST00000382519.4
ENST00000009180.4 |
CD9
|
CD9 molecule |
chr7_+_30174426 | 0.52 |
ENST00000324453.8
|
C7orf41
|
maturin, neural progenitor differentiation regulator homolog (Xenopus) |
chr15_-_41694640 | 0.52 |
ENST00000558719.1
ENST00000260361.4 ENST00000560978.1 |
NDUFAF1
|
NADH dehydrogenase (ubiquinone) complex I, assembly factor 1 |
chr14_-_75079026 | 0.52 |
ENST00000261978.4
|
LTBP2
|
latent transforming growth factor beta binding protein 2 |
chrX_+_150151824 | 0.51 |
ENST00000455596.1
ENST00000448905.2 |
HMGB3
|
high mobility group box 3 |
chr12_-_15082050 | 0.51 |
ENST00000540097.1
|
ERP27
|
endoplasmic reticulum protein 27 |
chr11_+_124933191 | 0.51 |
ENST00000532000.1
ENST00000308074.4 |
SLC37A2
|
solute carrier family 37 (glucose-6-phosphate transporter), member 2 |
chr11_+_124932986 | 0.49 |
ENST00000407458.1
ENST00000298280.5 |
SLC37A2
|
solute carrier family 37 (glucose-6-phosphate transporter), member 2 |
chr11_+_111789580 | 0.48 |
ENST00000278601.5
|
C11orf52
|
chromosome 11 open reading frame 52 |
chr7_+_30174668 | 0.48 |
ENST00000415604.1
|
C7orf41
|
maturin, neural progenitor differentiation regulator homolog (Xenopus) |
chr1_+_107599267 | 0.48 |
ENST00000361318.5
ENST00000370078.1 |
PRMT6
|
protein arginine methyltransferase 6 |
chr13_+_38923959 | 0.48 |
ENST00000379649.1
ENST00000239878.4 ENST00000437952.1 ENST00000379641.1 |
UFM1
|
ubiquitin-fold modifier 1 |
chr16_-_30102547 | 0.48 |
ENST00000279386.2
|
TBX6
|
T-box 6 |
chr12_-_48152853 | 0.47 |
ENST00000171000.4
|
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3 |
chr1_+_155051305 | 0.47 |
ENST00000368408.3
|
EFNA3
|
ephrin-A3 |
chrX_+_150151752 | 0.47 |
ENST00000325307.7
|
HMGB3
|
high mobility group box 3 |
chr15_+_81489213 | 0.46 |
ENST00000559383.1
ENST00000394660.2 |
IL16
|
interleukin 16 |
chr11_-_59633951 | 0.45 |
ENST00000257264.3
|
TCN1
|
transcobalamin I (vitamin B12 binding protein, R binder family) |
chr19_+_39687596 | 0.45 |
ENST00000339852.4
|
NCCRP1
|
non-specific cytotoxic cell receptor protein 1 homolog (zebrafish) |
chr9_-_35111420 | 0.45 |
ENST00000378557.1
|
FAM214B
|
family with sequence similarity 214, member B |
chr16_-_79633799 | 0.45 |
ENST00000569649.1
|
MAF
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog |
chr9_+_131644398 | 0.44 |
ENST00000372599.3
|
LRRC8A
|
leucine rich repeat containing 8 family, member A |
chrX_+_47444613 | 0.44 |
ENST00000445623.1
|
TIMP1
|
TIMP metallopeptidase inhibitor 1 |
chr19_-_39368887 | 0.44 |
ENST00000340740.3
ENST00000591812.1 |
RINL
|
Ras and Rab interactor-like |
chr11_+_124932955 | 0.44 |
ENST00000403796.2
|
SLC37A2
|
solute carrier family 37 (glucose-6-phosphate transporter), member 2 |
chr19_+_17416609 | 0.43 |
ENST00000602206.1
|
MRPL34
|
mitochondrial ribosomal protein L34 |
chr12_-_48152611 | 0.43 |
ENST00000389212.3
|
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3 |
chr1_-_17304771 | 0.43 |
ENST00000375534.3
|
MFAP2
|
microfibrillar-associated protein 2 |
chr22_-_21905120 | 0.43 |
ENST00000331505.5
|
RIMBP3C
|
RIMS binding protein 3C |
chr17_+_74380683 | 0.42 |
ENST00000592299.1
ENST00000590959.1 ENST00000323374.4 |
SPHK1
|
sphingosine kinase 1 |
chr12_-_123752624 | 0.42 |
ENST00000542174.1
ENST00000535796.1 |
CDK2AP1
|
cyclin-dependent kinase 2 associated protein 1 |
chr7_+_30174574 | 0.42 |
ENST00000409688.1
|
C7orf41
|
maturin, neural progenitor differentiation regulator homolog (Xenopus) |
chr7_+_143078652 | 0.41 |
ENST00000354434.4
ENST00000449423.2 |
ZYX
|
zyxin |
chr6_-_112194484 | 0.41 |
ENST00000518295.1
ENST00000484067.2 ENST00000229470.5 ENST00000356013.2 ENST00000368678.4 ENST00000523238.1 ENST00000354650.3 |
FYN
|
FYN oncogene related to SRC, FGR, YES |
chr1_-_154941350 | 0.41 |
ENST00000444179.1
ENST00000414115.1 |
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1 |
chr6_+_30852130 | 0.40 |
ENST00000428153.2
ENST00000376568.3 ENST00000452441.1 ENST00000515219.1 |
DDR1
|
discoidin domain receptor tyrosine kinase 1 |
chr8_-_135522425 | 0.40 |
ENST00000521673.1
|
ZFAT
|
zinc finger and AT hook domain containing |
chr1_+_19967014 | 0.40 |
ENST00000428975.1
|
NBL1
|
neuroblastoma 1, DAN family BMP antagonist |
chr11_+_46299199 | 0.39 |
ENST00000529193.1
ENST00000288400.3 |
CREB3L1
|
cAMP responsive element binding protein 3-like 1 |
chr8_-_139926236 | 0.39 |
ENST00000303045.6
ENST00000435777.1 |
COL22A1
|
collagen, type XXII, alpha 1 |
chr5_+_139927213 | 0.39 |
ENST00000310331.2
|
EIF4EBP3
|
eukaryotic translation initiation factor 4E binding protein 3 |
chr1_+_12538594 | 0.39 |
ENST00000543710.1
|
VPS13D
|
vacuolar protein sorting 13 homolog D (S. cerevisiae) |
chr9_+_131644388 | 0.38 |
ENST00000372600.4
|
LRRC8A
|
leucine rich repeat containing 8 family, member A |
chr13_+_102104952 | 0.38 |
ENST00000376180.3
|
ITGBL1
|
integrin, beta-like 1 (with EGF-like repeat domains) |
chr11_+_118401899 | 0.38 |
ENST00000528373.1
ENST00000544878.1 ENST00000354284.4 ENST00000533137.1 ENST00000532762.1 ENST00000526973.1 ENST00000354064.7 ENST00000533102.1 ENST00000313236.5 ENST00000527267.1 ENST00000524725.1 ENST00000533689.1 |
TMEM25
|
transmembrane protein 25 |
chr9_+_131644781 | 0.37 |
ENST00000259324.5
|
LRRC8A
|
leucine rich repeat containing 8 family, member A |
chr8_-_112248400 | 0.37 |
ENST00000519506.1
ENST00000522778.1 |
RP11-946L20.4
|
RP11-946L20.4 |
chr16_+_71660079 | 0.36 |
ENST00000565261.1
ENST00000268485.3 ENST00000299952.4 |
MARVELD3
|
MARVEL domain containing 3 |
chr14_-_24806588 | 0.36 |
ENST00000555591.1
ENST00000554569.1 |
RP11-934B9.3
RIPK3
|
Uncharacterized protein receptor-interacting serine-threonine kinase 3 |
chr5_+_3596168 | 0.36 |
ENST00000302006.3
|
IRX1
|
iroquois homeobox 1 |
chr16_+_4606347 | 0.36 |
ENST00000444310.4
|
C16orf96
|
chromosome 16 open reading frame 96 |
chr17_+_77681075 | 0.36 |
ENST00000397549.2
|
CTD-2116F7.1
|
CTD-2116F7.1 |
chr12_+_56473628 | 0.36 |
ENST00000549282.1
ENST00000549061.1 ENST00000267101.3 |
ERBB3
|
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3 |
chr11_-_2170786 | 0.35 |
ENST00000300632.5
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
chr9_+_135937365 | 0.35 |
ENST00000372080.4
ENST00000351304.7 |
CEL
|
carboxyl ester lipase |
chr6_+_53948328 | 0.35 |
ENST00000370876.2
|
MLIP
|
muscular LMNA-interacting protein |
chr6_+_30852738 | 0.34 |
ENST00000508312.1
ENST00000512336.1 |
DDR1
|
discoidin domain receptor tyrosine kinase 1 |
chr1_-_33647267 | 0.34 |
ENST00000291416.5
|
TRIM62
|
tripartite motif containing 62 |
chr3_+_189349162 | 0.34 |
ENST00000264731.3
ENST00000382063.4 ENST00000418709.2 ENST00000320472.5 ENST00000392460.3 ENST00000440651.2 |
TP63
|
tumor protein p63 |
chr7_+_143079000 | 0.34 |
ENST00000392910.2
|
ZYX
|
zyxin |
chr1_+_92632542 | 0.34 |
ENST00000409154.4
ENST00000370378.4 |
KIAA1107
|
KIAA1107 |
chr3_+_182511266 | 0.33 |
ENST00000323116.5
ENST00000493826.1 |
ATP11B
|
ATPase, class VI, type 11B |
chr6_-_66417107 | 0.33 |
ENST00000370621.3
ENST00000370618.3 ENST00000503581.1 ENST00000393380.2 |
EYS
|
eyes shut homolog (Drosophila) |
chr1_+_14075903 | 0.33 |
ENST00000343137.4
ENST00000503842.1 ENST00000407521.3 ENST00000505823.1 |
PRDM2
|
PR domain containing 2, with ZNF domain |
chr6_-_56716686 | 0.33 |
ENST00000520645.1
|
DST
|
dystonin |
chr6_+_150464155 | 0.33 |
ENST00000361131.4
|
PPP1R14C
|
protein phosphatase 1, regulatory (inhibitor) subunit 14C |
chr1_-_63782888 | 0.32 |
ENST00000436475.2
|
LINC00466
|
long intergenic non-protein coding RNA 466 |
chr10_-_62149433 | 0.32 |
ENST00000280772.2
|
ANK3
|
ankyrin 3, node of Ranvier (ankyrin G) |
chr18_+_43753500 | 0.32 |
ENST00000587591.1
ENST00000588730.1 |
C18orf25
|
chromosome 18 open reading frame 25 |
chr6_+_53948221 | 0.32 |
ENST00000460844.2
|
MLIP
|
muscular LMNA-interacting protein |
chr12_+_57916466 | 0.31 |
ENST00000355673.3
|
MBD6
|
methyl-CpG binding domain protein 6 |
chr18_+_43914159 | 0.31 |
ENST00000588679.1
ENST00000269439.7 ENST00000543885.1 |
RNF165
|
ring finger protein 165 |
chr1_+_14075865 | 0.31 |
ENST00000413440.1
|
PRDM2
|
PR domain containing 2, with ZNF domain |
chr17_+_74381343 | 0.31 |
ENST00000392496.3
|
SPHK1
|
sphingosine kinase 1 |
chr2_+_137523086 | 0.31 |
ENST00000409968.1
|
THSD7B
|
thrombospondin, type I, domain containing 7B |
chr18_+_47088401 | 0.31 |
ENST00000261292.4
ENST00000427224.2 ENST00000580036.1 |
LIPG
|
lipase, endothelial |
chr8_+_39972170 | 0.30 |
ENST00000521257.1
|
RP11-359E19.2
|
RP11-359E19.2 |
chr3_+_111717511 | 0.30 |
ENST00000478951.1
ENST00000393917.2 |
TAGLN3
|
transgelin 3 |
chr4_-_108204904 | 0.30 |
ENST00000510463.1
|
DKK2
|
dickkopf WNT signaling pathway inhibitor 2 |
chr1_-_207206092 | 0.29 |
ENST00000359470.5
ENST00000461135.2 |
C1orf116
|
chromosome 1 open reading frame 116 |
chr21_+_30503282 | 0.29 |
ENST00000399925.1
|
MAP3K7CL
|
MAP3K7 C-terminal like |
chr13_+_102104980 | 0.29 |
ENST00000545560.2
|
ITGBL1
|
integrin, beta-like 1 (with EGF-like repeat domains) |
chr20_+_58179582 | 0.29 |
ENST00000371015.1
ENST00000395639.4 |
PHACTR3
|
phosphatase and actin regulator 3 |
chr9_+_19408999 | 0.29 |
ENST00000340967.2
|
ACER2
|
alkaline ceramidase 2 |
chr10_-_64576105 | 0.28 |
ENST00000242480.3
ENST00000411732.1 |
EGR2
|
early growth response 2 |
chr10_-_98031265 | 0.28 |
ENST00000224337.5
ENST00000371176.2 |
BLNK
|
B-cell linker |
chr17_+_38333263 | 0.28 |
ENST00000456989.2
ENST00000543876.1 ENST00000544503.1 ENST00000264644.6 ENST00000538884.1 |
RAPGEFL1
|
Rap guanine nucleotide exchange factor (GEF)-like 1 |
chr4_+_7045042 | 0.28 |
ENST00000310074.7
ENST00000512388.1 |
TADA2B
|
transcriptional adaptor 2B |
chr14_+_24641820 | 0.28 |
ENST00000560501.1
|
REC8
|
REC8 meiotic recombination protein |
chrX_-_32173579 | 0.28 |
ENST00000359836.1
ENST00000343523.2 ENST00000378707.3 ENST00000541735.1 ENST00000474231.1 |
DMD
|
dystrophin |
chrX_-_102565932 | 0.28 |
ENST00000372674.1
ENST00000372677.3 |
BEX2
|
brain expressed X-linked 2 |
chr16_-_69385681 | 0.28 |
ENST00000288025.3
|
TMED6
|
transmembrane emp24 protein transport domain containing 6 |
chr12_-_109027643 | 0.27 |
ENST00000388962.3
ENST00000550948.1 |
SELPLG
|
selectin P ligand |
chr17_+_7255208 | 0.27 |
ENST00000333751.3
|
KCTD11
|
potassium channel tetramerization domain containing 11 |
chr5_+_66124590 | 0.27 |
ENST00000490016.2
ENST00000403666.1 ENST00000450827.1 |
MAST4
|
microtubule associated serine/threonine kinase family member 4 |
chr19_-_47164386 | 0.27 |
ENST00000391916.2
ENST00000410105.2 |
DACT3
|
dishevelled-binding antagonist of beta-catenin 3 |
chr7_+_18535346 | 0.27 |
ENST00000405010.3
ENST00000406451.4 ENST00000428307.2 |
HDAC9
|
histone deacetylase 9 |
chrX_-_131623043 | 0.27 |
ENST00000421707.1
|
MBNL3
|
muscleblind-like splicing regulator 3 |
chr19_-_6720686 | 0.26 |
ENST00000245907.6
|
C3
|
complement component 3 |
chr6_+_30848557 | 0.26 |
ENST00000460944.2
ENST00000324771.8 |
DDR1
|
discoidin domain receptor tyrosine kinase 1 |
chr15_+_44084503 | 0.26 |
ENST00000409960.2
ENST00000409646.1 ENST00000594896.1 ENST00000339624.5 ENST00000409291.1 ENST00000402131.1 ENST00000403425.1 ENST00000430901.1 |
SERF2
|
small EDRK-rich factor 2 |
chr11_+_118826999 | 0.26 |
ENST00000264031.2
|
UPK2
|
uroplakin 2 |
chr2_-_7005785 | 0.26 |
ENST00000256722.5
ENST00000404168.1 ENST00000458098.1 |
CMPK2
|
cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial |
chr14_+_62331592 | 0.26 |
ENST00000554436.1
|
CTD-2277K2.1
|
CTD-2277K2.1 |
chr5_+_148521381 | 0.26 |
ENST00000504238.1
|
ABLIM3
|
actin binding LIM protein family, member 3 |
chrX_+_9880590 | 0.25 |
ENST00000452575.1
|
SHROOM2
|
shroom family member 2 |
chr1_-_205391178 | 0.25 |
ENST00000367153.4
ENST00000367151.2 ENST00000391936.2 ENST00000367149.3 |
LEMD1
|
LEM domain containing 1 |
chr4_-_41216492 | 0.25 |
ENST00000503503.1
ENST00000509446.1 ENST00000503264.1 ENST00000508707.1 ENST00000508593.1 |
APBB2
|
amyloid beta (A4) precursor protein-binding, family B, member 2 |
chr19_-_41934635 | 0.24 |
ENST00000321702.2
|
B3GNT8
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8 |
chr9_+_131174024 | 0.24 |
ENST00000420034.1
ENST00000372842.1 |
CERCAM
|
cerebral endothelial cell adhesion molecule |
chr1_-_40367668 | 0.24 |
ENST00000397332.2
ENST00000429311.1 |
MYCL
|
v-myc avian myelocytomatosis viral oncogene lung carcinoma derived homolog |
chr12_+_46777450 | 0.24 |
ENST00000551503.1
|
RP11-96H19.1
|
RP11-96H19.1 |
chr3_-_178789220 | 0.24 |
ENST00000414084.1
|
ZMAT3
|
zinc finger, matrin-type 3 |
chr13_-_33780133 | 0.23 |
ENST00000399365.3
|
STARD13
|
StAR-related lipid transfer (START) domain containing 13 |
chr10_-_98031310 | 0.23 |
ENST00000427367.2
ENST00000413476.2 |
BLNK
|
B-cell linker |
chr4_+_2814011 | 0.23 |
ENST00000502260.1
ENST00000435136.2 |
SH3BP2
|
SH3-domain binding protein 2 |
chr1_+_180165672 | 0.23 |
ENST00000443059.1
|
QSOX1
|
quiescin Q6 sulfhydryl oxidase 1 |
chr11_+_64948665 | 0.23 |
ENST00000533820.1
|
CAPN1
|
calpain 1, (mu/I) large subunit |
chr2_+_7005959 | 0.23 |
ENST00000442639.1
|
RSAD2
|
radical S-adenosyl methionine domain containing 2 |
chr19_-_19051103 | 0.22 |
ENST00000542541.2
ENST00000433218.2 |
HOMER3
|
homer homolog 3 (Drosophila) |
chr1_+_104293028 | 0.22 |
ENST00000370079.3
|
AMY1C
|
amylase, alpha 1C (salivary) |
chr17_+_76165213 | 0.22 |
ENST00000590201.1
|
SYNGR2
|
synaptogyrin 2 |
chr9_+_92219919 | 0.22 |
ENST00000252506.6
ENST00000375769.1 |
GADD45G
|
growth arrest and DNA-damage-inducible, gamma |
chr3_+_72201910 | 0.22 |
ENST00000469178.1
ENST00000485404.1 |
LINC00870
|
long intergenic non-protein coding RNA 870 |
chr6_-_26250835 | 0.22 |
ENST00000446824.2
|
HIST1H3F
|
histone cluster 1, H3f |
chr11_+_117103441 | 0.22 |
ENST00000531287.1
ENST00000531452.1 |
RNF214
|
ring finger protein 214 |
chr14_+_24584508 | 0.22 |
ENST00000559354.1
ENST00000560459.1 ENST00000559593.1 ENST00000396941.4 ENST00000396936.1 |
DCAF11
|
DDB1 and CUL4 associated factor 11 |
chr10_+_75668916 | 0.22 |
ENST00000481390.1
|
PLAU
|
plasminogen activator, urokinase |
chr2_-_152590946 | 0.22 |
ENST00000172853.10
|
NEB
|
nebulin |
chr4_+_2813946 | 0.22 |
ENST00000442312.2
|
SH3BP2
|
SH3-domain binding protein 2 |
chr7_+_18535321 | 0.22 |
ENST00000413380.1
ENST00000430454.1 |
HDAC9
|
histone deacetylase 9 |
chr1_+_17559776 | 0.21 |
ENST00000537499.1
ENST00000413717.2 ENST00000536552.1 |
PADI1
|
peptidyl arginine deiminase, type I |
chr20_-_31124186 | 0.21 |
ENST00000375678.3
|
C20orf112
|
chromosome 20 open reading frame 112 |
chr2_+_69002052 | 0.21 |
ENST00000497079.1
|
ARHGAP25
|
Rho GTPase activating protein 25 |
chr19_+_50084561 | 0.21 |
ENST00000246794.5
|
PRRG2
|
proline rich Gla (G-carboxyglutamic acid) 2 |
chr19_-_49944806 | 0.21 |
ENST00000221485.3
|
SLC17A7
|
solute carrier family 17 (vesicular glutamate transporter), member 7 |
chr9_-_128003606 | 0.21 |
ENST00000324460.6
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) |
chr3_-_69370095 | 0.21 |
ENST00000473029.1
|
FRMD4B
|
FERM domain containing 4B |
chr3_+_183948161 | 0.21 |
ENST00000426955.2
|
VWA5B2
|
von Willebrand factor A domain containing 5B2 |
chr21_+_37692481 | 0.21 |
ENST00000400485.1
|
MORC3
|
MORC family CW-type zinc finger 3 |
chr22_-_36877371 | 0.20 |
ENST00000403313.1
|
TXN2
|
thioredoxin 2 |
chr19_-_36499521 | 0.20 |
ENST00000397428.3
ENST00000503121.1 ENST00000340477.5 ENST00000324444.3 ENST00000490730.1 |
SYNE4
|
spectrin repeat containing, nuclear envelope family member 4 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 4.6 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
0.5 | 3.2 | GO:0018032 | protein amidation(GO:0018032) |
0.4 | 1.6 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.3 | 1.0 | GO:1902362 | melanocyte apoptotic process(GO:1902362) |
0.3 | 1.6 | GO:0030807 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
0.3 | 3.2 | GO:0018377 | protein myristoylation(GO:0018377) |
0.3 | 0.8 | GO:0060279 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
0.3 | 0.8 | GO:0008057 | eye pigment granule organization(GO:0008057) |
0.3 | 1.3 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.2 | 0.7 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.2 | 2.8 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.2 | 0.6 | GO:1904404 | cellular response to vitamin B1(GO:0071301) response to formaldehyde(GO:1904404) |
0.2 | 0.8 | GO:0044752 | response to human chorionic gonadotropin(GO:0044752) |
0.2 | 0.5 | GO:0034970 | histone H3-R2 methylation(GO:0034970) |
0.1 | 0.4 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.1 | 1.5 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.7 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.1 | 0.4 | GO:0035697 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) positive regulation of necroptotic process(GO:0060545) regulation of T cell extravasation(GO:2000407) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
0.1 | 1.4 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.7 | GO:0070295 | renal water absorption(GO:0070295) |
0.1 | 0.5 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.1 | 1.1 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.1 | 2.2 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 1.3 | GO:0009414 | response to water deprivation(GO:0009414) |
0.1 | 0.7 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.1 | 0.5 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.1 | 0.3 | GO:0046707 | IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
0.1 | 0.4 | GO:0072086 | specification of loop of Henle identity(GO:0072086) pattern specification involved in metanephros development(GO:0072268) |
0.1 | 0.6 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.1 | 0.3 | GO:0002894 | positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
0.1 | 0.3 | GO:0007499 | ectoderm and mesoderm interaction(GO:0007499) |
0.1 | 0.4 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
0.1 | 0.3 | GO:0010983 | positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
0.1 | 1.7 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.1 | 0.4 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
0.1 | 0.4 | GO:0042441 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
0.1 | 0.2 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
0.1 | 0.4 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.1 | 0.2 | GO:0021589 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
0.1 | 1.0 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.1 | 0.3 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
0.1 | 0.5 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.1 | 0.2 | GO:1900108 | inner medullary collecting duct development(GO:0072061) negative regulation of nodal signaling pathway(GO:1900108) |
0.1 | 0.3 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.1 | 0.2 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.1 | 0.3 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.1 | 0.1 | GO:0055073 | cadmium ion homeostasis(GO:0055073) |
0.1 | 0.2 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.1 | 0.2 | GO:0008052 | sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
0.1 | 0.2 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
0.1 | 0.3 | GO:0072660 | maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
0.1 | 0.3 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.0 | 0.7 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
0.0 | 0.2 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.0 | 0.7 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
0.0 | 0.2 | GO:0036269 | swimming behavior(GO:0036269) |
0.0 | 0.4 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.0 | 0.2 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.0 | 0.2 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.0 | 0.4 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.0 | 0.2 | GO:0007525 | somatic muscle development(GO:0007525) |
0.0 | 0.1 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.0 | 0.2 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.0 | 1.2 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.0 | 0.2 | GO:0099640 | axo-dendritic protein transport(GO:0099640) |
0.0 | 0.3 | GO:0061739 | protein lipidation involved in autophagosome assembly(GO:0061739) |
0.0 | 0.4 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.5 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.0 | 0.2 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.0 | 0.2 | GO:0016240 | autophagosome docking(GO:0016240) |
0.0 | 0.2 | GO:2000639 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
0.0 | 0.2 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.0 | 0.1 | GO:0001808 | negative regulation of type IV hypersensitivity(GO:0001808) |
0.0 | 0.4 | GO:1905247 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
0.0 | 0.1 | GO:0035822 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.0 | 0.2 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.0 | 0.4 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.0 | 0.6 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 0.2 | GO:0060437 | lung growth(GO:0060437) |
0.0 | 0.2 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.0 | 0.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.0 | 0.2 | GO:1902045 | negative regulation of Fas signaling pathway(GO:1902045) |
0.0 | 0.6 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.0 | 0.0 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.0 | 0.1 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
0.0 | 0.1 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.0 | 0.3 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
0.0 | 0.3 | GO:2000580 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.0 | 0.4 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.0 | 0.1 | GO:0061056 | sclerotome development(GO:0061056) |
0.0 | 0.3 | GO:0034351 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
0.0 | 0.6 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.0 | 0.1 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.0 | 0.1 | GO:0009386 | translational attenuation(GO:0009386) |
0.0 | 0.9 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.6 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.0 | 0.1 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.0 | 0.5 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.0 | 0.2 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.0 | 0.1 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
0.0 | 0.4 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.0 | 0.1 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
0.0 | 0.3 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.0 | 0.1 | GO:0043553 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.0 | 0.2 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.0 | 0.7 | GO:0007398 | ectoderm development(GO:0007398) |
0.0 | 0.3 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.0 | 0.0 | GO:0007509 | mesoderm migration involved in gastrulation(GO:0007509) |
0.0 | 0.1 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) negative regulation of bicellular tight junction assembly(GO:1903347) |
0.0 | 0.1 | GO:0052331 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
0.0 | 0.3 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.0 | 0.0 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
0.0 | 0.2 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.0 | 0.1 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
0.0 | 0.2 | GO:0060056 | mammary gland involution(GO:0060056) |
0.0 | 0.6 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.0 | 0.4 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.0 | 0.1 | GO:0098912 | membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.0 | 0.4 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.1 | GO:1903045 | neural crest cell migration involved in sympathetic nervous system development(GO:1903045) |
0.0 | 0.4 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 0.1 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.0 | 0.4 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.0 | 0.2 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
0.0 | 0.3 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.0 | 1.2 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.0 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
0.0 | 0.1 | GO:0060844 | arterial endothelial cell fate commitment(GO:0060844) positive regulation of ephrin receptor signaling pathway(GO:1901189) positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |
0.0 | 0.0 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.0 | 0.5 | GO:0060384 | innervation(GO:0060384) |
0.0 | 0.2 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.0 | 1.0 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
0.0 | 0.1 | GO:0015870 | acetylcholine transport(GO:0015870) |
0.0 | 0.1 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.0 | 0.1 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.0 | 0.0 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
0.0 | 0.4 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.1 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.0 | 0.1 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.0 | 0.2 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.0 | 0.1 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.0 | 0.1 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.0 | 0.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.0 | 0.1 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.4 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.0 | 0.3 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.0 | 0.4 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.0 | 0.1 | GO:0021983 | pituitary gland development(GO:0021983) |
0.0 | 0.2 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.0 | 0.2 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.8 | GO:0043512 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
0.1 | 1.0 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.1 | 1.0 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.1 | 1.1 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 0.2 | GO:0033268 | node of Ranvier(GO:0033268) |
0.1 | 1.0 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 0.3 | GO:0031673 | H zone(GO:0031673) |
0.1 | 1.3 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 0.9 | GO:0097449 | astrocyte projection(GO:0097449) |
0.1 | 0.4 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.0 | 0.3 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.0 | 0.3 | GO:0016013 | syntrophin complex(GO:0016013) |
0.0 | 0.6 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.0 | 0.6 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.0 | 0.2 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.0 | 0.1 | GO:1990032 | parallel fiber(GO:1990032) |
0.0 | 1.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.1 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.0 | 1.8 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.0 | 0.2 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.0 | 0.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.0 | 0.4 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.0 | 0.3 | GO:0000322 | storage vacuole(GO:0000322) |
0.0 | 0.4 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.0 | 0.3 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.1 | GO:1990745 | EARP complex(GO:1990745) |
0.0 | 2.3 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.0 | 0.4 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.0 | 0.4 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 0.4 | GO:0097342 | ripoptosome(GO:0097342) |
0.0 | 0.3 | GO:0030914 | STAGA complex(GO:0030914) |
0.0 | 0.4 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.1 | GO:0000801 | central element(GO:0000801) |
0.0 | 0.3 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.1 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 2.5 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 0.3 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 0.2 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.0 | 0.3 | GO:0043194 | axon initial segment(GO:0043194) |
0.0 | 1.6 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 2.2 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.2 | GO:0044453 | nuclear membrane part(GO:0044453) |
0.0 | 0.2 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.0 | 0.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.0 | 0.7 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 0.2 | GO:0061700 | GATOR2 complex(GO:0061700) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 3.2 | GO:0004504 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
0.3 | 3.2 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.2 | 2.8 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.2 | 0.6 | GO:0061663 | NEDD8 ligase activity(GO:0061663) |
0.2 | 0.5 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
0.2 | 1.4 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.1 | 0.8 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.1 | 0.7 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.1 | 0.5 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.1 | 0.8 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.1 | 0.4 | GO:0071633 | dihydroceramidase activity(GO:0071633) |
0.1 | 0.7 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.1 | 1.0 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.1 | 1.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 1.6 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 0.6 | GO:0030172 | troponin C binding(GO:0030172) |
0.1 | 0.2 | GO:0035643 | L-DOPA receptor activity(GO:0035643) L-DOPA binding(GO:0072544) |
0.1 | 0.1 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 0.3 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.1 | 0.6 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 1.2 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.1 | 0.3 | GO:0019144 | ADP-sugar diphosphatase activity(GO:0019144) |
0.0 | 0.1 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
0.0 | 0.2 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.0 | 0.2 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.0 | 0.4 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.0 | 0.4 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.0 | 0.2 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
0.0 | 0.8 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.4 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.0 | 0.5 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.2 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.0 | 0.2 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
0.0 | 0.2 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.0 | 0.5 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.0 | 0.7 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.0 | 0.8 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.4 | GO:0016015 | morphogen activity(GO:0016015) |
0.0 | 0.3 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.0 | 1.2 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.5 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.1 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.0 | 0.2 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.0 | 1.0 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 1.0 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.0 | 1.2 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.4 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 0.6 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.0 | 0.2 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.0 | 0.1 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.0 | 0.4 | GO:0038132 | neuregulin binding(GO:0038132) |
0.0 | 0.1 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.0 | 0.1 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.0 | 0.1 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.0 | 0.2 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.0 | 0.5 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.0 | 0.2 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.0 | 0.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 0.2 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.0 | 0.3 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.0 | 0.2 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.0 | 0.3 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 0.2 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.0 | 0.1 | GO:0004968 | gonadotropin-releasing hormone receptor activity(GO:0004968) |
0.0 | 0.1 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.0 | 0.3 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.0 | 0.5 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.0 | 0.5 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 1.0 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.4 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.6 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 4.4 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.3 | GO:0089720 | caspase binding(GO:0089720) |
0.0 | 0.1 | GO:0098960 | postsynaptic neurotransmitter receptor activity(GO:0098960) |
0.0 | 0.3 | GO:0039706 | co-receptor binding(GO:0039706) |
0.0 | 0.9 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 1.1 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.1 | GO:0032038 | myosin II heavy chain binding(GO:0032038) |
0.0 | 1.4 | GO:0015485 | cholesterol binding(GO:0015485) |
0.0 | 0.0 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
0.0 | 0.1 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.0 | 0.2 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.0 | 0.3 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.0 | 0.1 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.0 | 0.1 | GO:0000150 | recombinase activity(GO:0000150) |
0.0 | 0.1 | GO:0005277 | acetylcholine transmembrane transporter activity(GO:0005277) acetate ester transmembrane transporter activity(GO:1901375) |
0.0 | 0.4 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 0.0 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.0 | 0.3 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.0 | 0.1 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.0 | 0.1 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.0 | 0.0 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
0.0 | 1.8 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.0 | 0.4 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.9 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 1.1 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.0 | 4.6 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 1.3 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.6 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 1.0 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.8 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.5 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 1.8 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 2.0 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.6 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.6 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.2 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.3 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.1 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.8 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 0.1 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 1.0 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.1 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 1.5 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 0.6 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 0.8 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 3.8 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 0.8 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 1.7 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.4 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.2 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.0 | 0.6 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.6 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.0 | 2.1 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 1.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.6 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.4 | REACTOME SHC MEDIATED CASCADE | Genes involved in SHC-mediated cascade |
0.0 | 0.2 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.2 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.0 | 0.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 0.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.3 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 0.4 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.5 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 0.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.7 | REACTOME G1 PHASE | Genes involved in G1 Phase |